Oral P2Y12 inhibitors represent the mainstay therapy for the prevention of thrombotic complications in patients undergoing percutaneous coronary intervention (PCI) and coronary stent implantation. However, the onset of antiplatelet action of the oral P2Y12 inhibitors is affected by their need to be absorbed in the gast...
F. Pelliccia, G. Andò, P. Capranzano et al.· International Journal of Car...· 0 citations
Objectives
Up to 40% of patients with aortic stenosis undergoing valve replacement have a small annulus, a key determinant of valve hemodynamics, durability, and clinical outcomes. Surgical and transcatheter approaches have been reported to be determined by prosthesis design, considering the operative mortality and mor...
J. Chiabrando, M. Lombardi, E. Elia et al.· The Journal of invasive card...· 0 citations
In patients with acute MI undergoing PCI, first-line evolocumab combined with high-intensity lipid-lowering therapy produced rapid and sustained LDL-C reduction, with more than 80% of patients reaching the guideline-recommended target at 1 year.
G. Montalescot, E. Ferrari, G. Souteyrand et al.· Journal of the American Medi...· 3 citations
Lower baseline TAPSE/PASP was independently associated with atrial fibrillation recurrence, supporting the role of RV-PA uncoupling as a potential marker for postablation risk stratification.
Andrea Bonelli, A. Degiovanni, A. Cersosimo et al.· Journal of Cardiovascular Me...· 0 citations
Among CCS patients, LMCAD/LMCAD-equivalent can be excluded with high negative predictive value through a model based on clinical and EST parameters, allowing initial non-invasive management of most patients able to exercise.
M. D. De Carlo, M. A. Malanima, L. Baglietto et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
